Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says

MT NewswiresNov 28 00:21

Grail Initiated at Equal Weight by Morgan Stanley

Seeking AlphaNov 28 00:03

GRAIL Analyst Ratings

BenzingaNov 28 00:02 · Ratings

Morgan Stanley Initiates GRAIL at Equalweight With $16 Price Target

MT NewswiresNov 27 19:15 · Ratings

Balanced Risk/Reward Scenario: Hold Rating for GRAIL Inc Amid Regulatory and Financial Challenges

TipRanksNov 27 17:36

Institutional Investors in GRAIL, Inc. (NASDAQ:GRAL) Have Had a Wonderful Week After Share Price Increased 12%

Simply Wall StNov 24 22:41